Related Experiment Videos
CTLA-4 (CD152) and its involvement in autoimmune disease
Dan Holmberg1, Corrado M Cilio, Marie Lundholm
1Department of Medical Biosciences, Umeå University, Sweden. dan.holmberg@ucmm.umu.se
Autoimmunity
|August 30, 2005
Summary
Autoimmune diseases share genetic factors, with CD152 emerging as a key susceptibility gene. This review explores CD152
Area of Science:
- Immunology
- Genetics
- Autoimmunity
Background:
- Autoimmune diseases (AID) are complex genetic disorders often clustering within families, suggesting shared etiological factors.
- Identifying specific genetic susceptibility factors for AID beyond the major histocompatibility complex (MHC) has been challenging.
- The CD152 molecule has been proposed as a potential unifying genetic factor across various autoimmune conditions.
Purpose of the Study:
- To review the evidence supporting CD152 as a general susceptibility factor for multiple autoimmune diseases.
- To discuss the role of CD152 and related co-stimulatory pathways in the pathogenesis of autoimmune diseases.
Main Methods:
- Literature review of genetic studies and immunological research on autoimmune diseases.
- Analysis of data linking CD152 (CTLA-4) gene variants to autoimmune disease susceptibility.
- Review of experimental evidence on CD152 function in immune regulation.
Main Results:
- Evidence suggests CD152 is a significant susceptibility factor for a range of autoimmune diseases.
- Polymorphisms in the CD152 gene are associated with increased risk for several AID.
- CD152 plays a crucial role in regulating T-cell responses, and its dysfunction can promote autoimmunity.
Conclusions:
- CD152 represents a common genetic susceptibility factor for multiple autoimmune diseases.
- Dysregulation of CD152 and co-stimulatory pathways is implicated in the development of autoimmune pathogenesis.
- Targeting CD152 pathways may offer therapeutic strategies for autoimmune conditions.